237 related articles for article (PubMed ID: 8104960)
1. Combination drug therapy with calcium-channel blockers in the treatment of systemic hypertension.
Frishman WH; Landau A; Cretkovic A
J Clin Pharmacol; 1993 Aug; 33(8):752-5. PubMed ID: 8104960
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of myocardial ischemia with reference to blood pressure values].
Schneeweiss A; Wiegand V
Cardiology; 1993; 82 Suppl 2():58-65. PubMed ID: 8100187
[No Abstract] [Full Text] [Related]
3. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
Morgan TO; Anderson AI; MacInnis RJ
Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
[TBL] [Abstract][Full Text] [Related]
4. Individualized antianginal therapy guided by systemic arterial pressure.
Schneeweiss A; Reisin L
Am J Cardiol; 1990 Jun; 65(21):2J-5J. PubMed ID: 1971990
[TBL] [Abstract][Full Text] [Related]
5. Management of hypertension. What is the role of beta blockers?
Gifford RW
Postgrad Med; 1988 Feb; Spec No():46-9. PubMed ID: 2894661
[TBL] [Abstract][Full Text] [Related]
6. Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease.
Rosendorff C
Expert Opin Pharmacother; 2003 Sep; 4(9):1535-41. PubMed ID: 12943483
[TBL] [Abstract][Full Text] [Related]
7. [Control of blood pressure in prevention of hypertensive end-organ damage].
Kido M; Ando K; Fujita T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
[No Abstract] [Full Text] [Related]
8. Has the role of calcium channel blockers in treating hypertension finally been defined?
Chrysant GS; Chrysant SG
Curr Hypertens Rep; 2003 Aug; 5(4):295-300. PubMed ID: 12844463
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
10. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
11. Urocortin 2 in patients with hypertension treated with angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Walczewska J; Siga O; Dzieza-Grudnik A; Krolczyk J; Wizner B; Wolkow PP; Borys A; Kolton-Wroz M; Gryglewska B; Grodzicki T
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443094
[TBL] [Abstract][Full Text] [Related]
12. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
13. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
Lemmer B
Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Bath P
Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
[No Abstract] [Full Text] [Related]
15. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease.
O'Rourke RA
Am J Cardiol; 1985 Dec; 56(16):34H-40H. PubMed ID: 2866705
[TBL] [Abstract][Full Text] [Related]
16. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
17. Is it time for a new approach to the initial treatment of hypertension?
Moser M
Arch Intern Med; 2001 May; 161(9):1140-4. PubMed ID: 11343437
[No Abstract] [Full Text] [Related]
18. Medical management of myocardial ischemia.
Sander GE; Giles TD
Am J Geriatr Cardiol; 2005; 14(4):205-9. PubMed ID: 16015063
[No Abstract] [Full Text] [Related]
19. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers.
Aronow WS; Ahn C
Am J Cardiol; 2002 May; 89(10):1207-9. PubMed ID: 12008178
[No Abstract] [Full Text] [Related]
20. Intraclass differences among antihypertensive drugs.
Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
